Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: A frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial

Cancer Research

Volumn 57, Issue 9, 1997, Pages 1769-1775

  Augenlicht, Leonard H ^a   Wadler, Scott ^a   Corner, Georgia ^a   Richards, Christine ^a   Ryan, Louise ^b   Multani, Asha S ^c   Pathak, Sen ^c   Benson, Al ^d   Haller, Daniel ^e   Heerdt, Barbara G ^a  

^a ALBERT EINSTEIN CANCER CENTER   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; LEVAMISOLE; PROTEIN P53;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CARCINOMA CELL; CHROMOSOME 8Q; CLINICAL TRIAL; COLON CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ONCOGENE C MYC; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE;

CARCINOMA; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; DNA, NEOPLASM; FLUOROURACIL; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; GENES, P53; HUMANS; MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 15644372023     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Sheiness, D., and Bishop, J. M. DNA and RNA from uninfected vertebrate cells contain nucleotide sequences related to the putative transforming gene of avian myelocytomatosis virus. J. Virol., 31: 514-521, 1979.
2. Watson, D., Psallidopoulos, M., Samuel, K., Dalla-Favera, R., and Papas, T. Nucleotide sequence analysis of human c-myc locus, chicken homologue, and myelocytomatosis virus MC29 transforming gene reveals a highly conserved gene product. Proc. Natl. Acad. Sci. USA, 80: 3642-3645, 1983.
3. Yander, G., Halsey, H., Kenna, M., and Augenlicht, L. H. Amplification and elevated expression of c-myc in a chemically induced mouse colon tumor. Cancer Res., 45: 4433-4438, 1935.
4. Erisman, M. D., Rothberg, P. G., Diehl, R. E., Morse, C. C., Spandorfer, J. M., and Astrin, S. M. Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene. Mol. Cell. Biol., 5: 1969-1976, 1985.
5. Erisman, M. D., Scott, J. K., Watt, R. A., and Astrin, S. M. The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines. Oncogene, 2: 367-378, 1988.
6. Sikora, A., Chan, S., Evan, G., Gabra, H., Markham, N., Stewart, J., and Watson, J. c-myc oncogene expression in colorectal cancer. Cancer (Phila.), 59: 1289-1295, 1987.
7. Finely, G. G., Schulz., N. T., Hill, S. A., Geiser, J. R., Pipas, J. M., and Meisler, A. I. Expression of the myc gene family in different stages of human colorectal cancer. Oncogene, 4: 963-971, 1989.
8. Heerdt, B. G., Molinas, S., Deitch, D., and Augenlicht, L. H. Aggressive subtypes of human colorectal tumors frequently exhibit amplification of the c-myc gene. Oncogene, 6: 125-129, 1991.
9. Heerdt, B. G., and Augenlicht, L. H. Changes in the number of mitochondrial genomes during human development. Exp. Cell Res., 186: 54-59, 1990.
10. Dalla-Favera, R., Martinotti, S., Gallo, R. C., Erikson, J., and Croce, C. M. Trans-location and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. Science (Washington DC), 219: 963-967, 1983.
11. Collins, F. S., and Weissman, S. M. The molecular genetics of human hemoglobin. Prog. Nucleic Acid Res. Mol. Biol., 31: 315-462, 1984.
12. Heerdt, B. G., and Augenlicht, L. H. Effects of fatty acids on expression of genes encoding subunits of cytochrome c oxidase and cytochrome c oxidase activity in HT29 human colonic adenocarcinoma cells. J. Biol. Chem., 266: 19120-19126, 1991.
13. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
14. Peto, R., and Peto, J. Asymptotically efficient rank invariant test procedures (with discussion). J. R. Stat. Assoc. Ser. A Gen., 135: 185-206, 1972.
15. Alitalo, K., Schwab, M., Lin, C. C., Varmus, H. E., and Bishop, J. M. Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. Proc. Natl. Acad. Sci. USA, 80: 1707-1711, 1983.
16. Forgue-Lafitte, M-E., Coudray, A-M., Breant, B., and Mester, J. Proliferation of the human colon carcinoma cell line HT29: autocrine growth and deregulated expression of the c-myc oncogene. Cancer Res., 49: 6566-6571, 1989.
17. Moertel, C. G., Fleming, T. R., Macdonald, J. S., Haller, D. G., Laurie, J. A., Tangen, C. M., Ungerleider, J. S., Emerson, W. A., Tormey, D. C., Glick, J. H., Veeder, M. H., and Maillaird, J. A. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann. Intern. Med., 5: 321-326, 1995.
18. Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., vanTuinen, P., Ledbetter, D. H., Barker, D. F., Nakamura, Y., White, R., and Vogelstein, B. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science (Washington DC), 244: 217-221, 1989.
19. Baker, S. J., Preisinger, A. C., Jessup, J. M., Paraskeva, C., Markowitz, S., Willson, J. K. V., Hamilton, S., and Vogelstein, B. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res., 50: 7717-7722, 1990.
20. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
21. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304-6311, 1991.
22. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., and Kastan, M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA, 89: 7491-7495, 1992.
23. Hartwell, L. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell, 71: 543-546, 1992.
24. Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., and Tisty, T. D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type P53. Cell, 70: 923-935, 1992.
25. Moertel, C. G., Fleming, T. R., Macdonald, J. S., Haller, D. G., Laurie, J. A., Goodman, P. J., Ungerleider, J. R., Emerson, W. A., Tormey, D. C., Glick, J. H., Veeder, M. H., and Maillaird, J. A. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N. Engl. J. Med., 322: 352-358, 1990.
26. Steele, G. D., Augenlicht, L. H., Begg, C. B., Gelber, R. D., Green, M. R., Kinsella, T. J., Niederhuber, J. E., Phillips, T. L., Williams, B., Winawer, S. J., Winchester, D. P., Winn, R. J., and Young, R. C. Adjuvant therapy for patients with colon and rectal cancer. J. Am. Med. Assoc., 264: 1444-1450, 1990.
27. Solomon, E., Voss, R., Hall, V., Bodmer, W. F., Jass, J. R., Jeffreys, A. J., Lucibello, F. C., Patel, I., and Rider, S. H. Chromosome 5 allele loss in human colorectal carcinomas. Nature (Lond.), 328: 616-619, 1987.
28. Levy, D. B., Smith, K. J., Beazer-Barclay, Y., Hamilton, S. R., Vogelstein, B., and Kinzler, K. W. Inactivation of both APC alleles in human and mouse tumors. Cancer Res., 54: 5953-5958, 1994.
29. Chu, E., Takechi, T., Jones, K. L., Voeller, D. M., Copur, S. M., Maley, G. F., Maley, F., Segal, S., and Allegra, C. J. Thymidylate synthase binds to c-myc RNA in human colon cancer cells and in vitro. Mol. Cell. Biol., 15: 179-185, 1995.
30. Horikoshi, T., Danenberg, K. D., Stadlbauer, T. H. W., Vokenandt, M., Shea, L. C. C., Aigner, K., Gustavsson, B., Leichman, L., Frosing, R., Ray, M., Gibson, N. W., Spears, C. P., and Danenberg, P. V. Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res., 52: 108-116, 1992.
31. Chu, E., Koeller, D. M., Casey, J. L., Drake, J. C., Chabner, B. A., Elwood, P. C., Zinn, S., and Allegra, C. J. Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase. Proc. Natl. Acad. Sci. USA, 88: 8977-8981, 1991.
32. Erisman, M. D., Scott, J. K., and Astrin, S. M. Evidence that the familial adenomatous polyposis gene is involved in a subset of colon cancers with a complementable defect in c-myc regulation. Proc. Natl. Acad. Sci. USA, 86: 4264-4268, 1989.
33. Rodriguez-Alfageme, C., Stanbridge, E. J., and Astrin, S. M. Suppression of deregulated c-MYC expression in human colon carcinoma cells by chromosome 5 transfer. Proc. Natl. Acad. Sci. USA, 89: 1482-1486, 1992.
34. Powell, S. M., Zilz, N., Beazer-Barclay, Y., Bryan, T. M., Hamilton, S. R., Thibodeau, S. N., Vogelstein, B., and Kinzler, K. APC mutations occur early during colorectal tumorigenesis. Nature (Lond.), 359: 235-237, 1992.
35. Kallioniemi, A., Kallioniemi, O-P., Sudar, D., Rutovitz, D., Gray, J. W., Waldman, F., and Pinkel, D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science (Washington DC), 258: 818-821, 1992.
36. Kallioniemi, A., Kallioniemi, O-P., Piper, J., Tanner, M., Stokke, T., Chen, L., Smith, H. S., Pinkel, D., Gray, J. W., and Waldman, F. M. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc. Natl. Acad. Sci. USA, 91: 2156-2160, 1994.
37. Ried, T., Petersen, I., Holtgreve-Grez, H., Speicher, M. R., Schrock, E., Manoir, S. D., and Cremer, T. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res., 54: 1801-1806, 1994.
38. Gordon, K. B., Thompson, C. T., Char, D. H., O'Brien, J. M., Kroll, S., Ghazvini, S., and Gray, J. W. Comparative genomic hybridization in the detection of DNA copy number abnormalities in uveal melanoma. Cancer Res., 54: 4764-4768, 1994.
39. Guan, X-Y., Meltzer, P. S., Dalton, W. S., and Trent, J. M. Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection. Nat. Genet., 8: 155-161, 1994.
40. Guan, X-Y., Cargile, C. B., Anzick, S. L., Thompson, F. H., Meltzer, P. S., Bittner, M. L., Taetle, R., McGill, J. R., and Trent, J. M. Chromosome microdissection identifies cryptic sites of DNA sequence amplification in human ovarian carcinoma. Cancer Res., 55: 3380-3385, 1995.
41. Visakorpi, T., Kallioniemi, A. H., Syvanen, A-C., Hyytinen, E. R., Karhu, R., Tammela, T., Isola, J. J., and Kallioniemi, O-P. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res., 55: 342-347, 1995.
42. Vogelstein, B., Fearon, E. R., Kern, S. E., Hamilton, S. R., Preisinger, A. C., Nakamura, Y., and White, R. Allelotype of colorectal carcinomas. Science (Washington DC), 244: 207-211, 1989.
43. Augenlicht, L. H., Wahrman, M. Z., Halsey, H., Anderson, L., Taylor, J., and Lipkin, M. Expression of cloned sequences in biopsies of human colonic tissue and in colonie carcinoma cells induced to differentiate in vitro. Cancer Res., 47: 6017-6021, 1987.
44. Augenlicht, L. H. Gene expression in human colonie biopsies. In: G. Steele, R. Burt, S. J. Winawer, and J. P. Karr (eds.), Basic and Clinical Perspectives of Colorectal Polyps and Cancer, pp. 195-202. New York: Alan R. Liss, Inc., 1988.
45. Augenlicht, L. H., Taylor, J., Anderson, L., and Lipkin, M. Patterns of gene expression that characterize the colonie mucosa in patients at genetic risk for colonie cancer. Proc. Natl. Acad. Sci. USA, 88: 3286-3289, 1991.
46. Augenlicht, L. H., and Heerdt, B. G. Modulation of gene expression as a biomarker in colon. J. Cell. Biochem., 16G: 151-157, 1992.
47. Augenlicht, L. H., and Heerdt, B. G. Colonie carcinoma: a common tumor with multiple genomic abnormalities. In: T. Pretlow and T. Pretlow (eds.), Biochemical and Molecular Aspects of Selected Cancers. Vol. 2, pp. 47-91. New York: Academic Press, 1994.